Skip to main content
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 2020 Oct 22;117(45):28026–28035. doi: 10.1073/pnas.2008175117

SurA is a cryptically grooved chaperone that expands unfolded outer membrane proteins

Dagan C Marx a, Ashlee M Plummer a,1, Anneliese M Faustino b, Taylor Devlin a, Michaela A Roskopf a, Mathis J Leblanc a, Henry J Lessen a, Barbara T Amann a, Patrick J Fleming a, Susan Krueger c, Stephen D Fried b, Karen G Fleming a,2
PMCID: PMC7668074  PMID: 33093201

Significance

Outer membrane proteins play critical roles in bacterial physiology and increasingly are exploited as antibiotic targets. SurA is the most important chaperone in the OMP biogenesis network and is thought to initiate their folding through an interaction with the BAM complex. We observe an unprecedented expansion of unfolded outer membrane proteins when bound to SurA. This expansion suggests a potential mechanism by which SurA can deliver uOMPs to the BAM complex. In addition, this study highlights the use of an integrative/hybrid structural biology approach and emerging methods to map highly heterogeneous structural ensembles, such as that of an unfolded protein bound to a chaperone.

Keywords: periplasmic chaperones, outer membrane protein biogenesis, crosslinking mass spectrometry, small-angle neutron scattering, integrative/hybrid structural biology

Abstract

The periplasmic chaperone network ensures the biogenesis of bacterial outer membrane proteins (OMPs) and has recently been identified as a promising target for antibiotics. SurA is the most important member of this network, both due to its genetic interaction with the β-barrel assembly machinery complex as well as its ability to prevent unfolded OMP (uOMP) aggregation. Using only binding energy, the mechanism by which SurA carries out these two functions is not well-understood. Here, we use a combination of photo-crosslinking, mass spectrometry, solution scattering, and molecular modeling techniques to elucidate the key structural features that define how SurA solubilizes uOMPs. Our experimental data support a model in which SurA binds uOMPs in a groove formed between the core and P1 domains. This binding event results in a drastic expansion of the rest of the uOMP, which has many biological implications. Using these experimental data as restraints, we adopted an integrative modeling approach to create a sparse ensemble of models of a SurA•uOMP complex. We validated key structural features of the SurA•uOMP ensemble using independent scattering and chemical crosslinking data. Our data suggest that SurA utilizes three distinct binding modes to interact with uOMPs and that more than one SurA can bind a uOMP at a time. This work demonstrates that SurA operates in a distinct fashion compared to other chaperones in the OMP biogenesis network.


Proteins must fold into their native three-dimensional structures to perform their functions. For some proteins, this folding process is spontaneous and requires no exogenous factors; however, many proteins—particularly membrane proteins—are predisposed to populate misfolded states or aggregates that are not functional and can be toxic to the cell (13). To suppress these pathways, chaperone proteins promote efficient protein folding through interactions with nascent, unfolded proteins (termed clients) (48).

One chaperone network of particular importance is the outer membrane protein (OMP) biogenesis network in gram-negative bacteria. Following translocation across the inner membrane, this network solubilizes hydrophobic, unfolded OMPs (uOMPs) in the aqueous periplasm and delivers them to the β-barrel assembly machine (BAM) complex, which catalyzes uOMP folding into the outer membrane (913). OMPs play several critical roles in bacterial physiology, such as nutrient uptake, lipid remodeling, and efflux (14). Recently, the OMP biogenesis pathway has been exploited as a target for the development of antibiotics against gram-negative bacteria because drugs that compromise essential OMP maturation need only cross the fairly porous outer membrane and not the tightly regulated inner membrane (1517).

The OMP biogenesis chaperone network is comprised of three proteins: SurA, which has been shown to be the most important protein in the pathway, as well as Skp and FkpA (1823). SurA handles the majority of the flux of uOMPs through the periplasm, and, accordingly, a ∆surA-null strain induces a pronounced envelope stress response (9, 18, 2429). Eight OMPs of varying size (8 to 26 transmembrane β-strands) and sequence composition have been identified as SurA clients because their expression is notably decreased in the ∆surA strain (14, 28, 3032).

The mechanism by which SurA binds and solubilizes client uOMPs is currently unknown. The lack of adenosine 5′-triphosphate (ATP) in the periplasm implies that the driving forces for SurA’s function must derive from interactions with its clients. Unlike the other members of the OMP biogenesis network that oligomerize to form cages around uOMPs, SurA lacks an obvious cavity to shield uOMPs from the aqueous periplasm and does not readily oligomerize in solution (9). Instead, SurA has a modular structure with three distinct domains connected by flexible linkers shown in Fig. 1A: a primarily alpha helical “core” domain comprised of portions from the N- and C-terminal regions, and two peptidyl prolyl isomerase (PPIase) domains (P1 and P2) (3336). The orientations of the P1 and P2 domains relative to the core domain have been shown to be dynamic although how the SurA conformational ensemble contributes to uOMP binding is unclear (22, 3739). The core domain of SurA is thought to be responsible for the majority of the binding energy to small, eight-stranded uOMPs and alone can complement the ∆surA strain of Escherichia coli (22, 30, 4048).

Fig. 1.

Fig. 1.

Open SurA binds client uOMPs in a groove between domains. (A) The structure of open SurA shown as a schematic, with the domains colored as depicted in the sequence diagram below (core, gray; P1, blue; P2, red). In this conformation, the three domains of SurA are structurally isolated from each other and do not form extensive interdomain contacts. (B) The 32 surface exposed sites on SurA in which pAF was substituted, shown in a space-filling representation. Photo-crosslinking was induced with 5-min UV exposure. Each crosslinking site is colored based on the normalized crosslinking efficiency to uOmpA171 as based on quantitative SDS/PAGE (SI Appendix, Fig. S2). The highest crosslinking sites are found on the core and P1 domains of SurA while P2 exhibits only modest crosslinking efficiency. (C) The raw crosslinking efficiencies of SurA to uOmpA171 and uOmpX are shown and colored by the SurA domain in which they residue (as in A). Eight SurApAF variants stand out by having high (>40%) crosslinking efficiency to both uOMP clients and are labeled with their residue number in the upper right quadrant of the graph (demarcated by dotted lines). (D) The eight high efficiency crosslinking sites, shown in magenta, are mapped onto a surface representation of the structure of open SurA. Together, these sites line a groove formed between the core and P1 domains, indicating that uOMPs are primarily bound there.

Structural elucidation of a SurA•uOMP conformation is challenging. As discussed above, SurA has been shown to exist in multiple conformations. Moreover, the unfolded nature of client OMPs poses several additional hurdles that have impeded structural characterization by classical techniques: uOMPs lack regular secondary structure, are highly dynamic, and are prone to aggregation (4952). We address these challenges by capitalizing on the power of an integrative/hybrid structural biology approach that combines data from crosslinking, mass spectrometry, and neutron scattering to elucidate structural features of the SurA•uOMP ensemble. By incorporating photo-crosslinking unnatural amino acids throughout SurA, we find SurA sites with the highest crosslinking efficiencies to clients line a groove formed between the core and P1 domains. Contrast-matching small angle neutron scattering (SANS) of a crosslinked complex reveals that a canonical uOMP client is greatly expanded when bound to SurA. Mass spectrometry analysis of the photo-crosslinked SurA–uOMP complexes identifies specific segments on client uOMPs that preferentially interact with the SurA groove.

Using our experimental data as restraints, we created a sparse ensemble of 40 configurations of SurA•uOMP complexes. We validated structural features present in this ensemble with additional chemical crosslinking mass spectrometry and SANS experiments that were not included in model generation. We identified three distinct uOMP binding modes and higher order stoichiometries that were sufficient to explain the data. Overall, our findings provide a structural basis for how SurA solubilizes its uOMP clients and provide a template for how future studies might elucidate the structures of highly dynamic chaperone complexes with unfolded proteins.

Results

SurA Crosslinks Preferentially with Client uOMPs.

We identified regions of SurA involved in binding uOMPs using short-distance crosslinkers across the surface of SurA. To accomplish this, we incorporated the unnatural amino acid, para-azido-phenylalanine (pAF), at 32 nonconserved, surface-exposed positions on SurA (Fig. 1B and SI Appendix, Fig. S1) using amber suppression (53). pAF is a “zero-length” crosslinker because it forms highly reactive intermediates that crosslink rapidly and nonspecifically to any residue within 3 to 4 Å (although one crosslinking mechanism has been shown to slightly favor reactions with aromatic amino acids) (54, 55). Previously applied in biochemical assays, we report here the application of pAF crosslinking for structural studies (56, 57).

Each SurA variant with a single amino acid substituted for pAF (denoted SurApAF) was mixed with one of three uOMPs: clients uOmpA171 (the transmembrane domain of uOmpA) (SI Appendix, SI Methods) and uOmpX, or the nonclient uOmpLA as a negative control (31, 58). Samples were exposed to ultraviolet (UV) light for 5 min, and crosslinking efficiency was measured by quantitative sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS/PAGE) (SI Appendix, Fig. S2 and Table S1) (59). Crosslinking efficiencies to the two client uOMPs vary dramatically with position on SurA, with the highest efficiency sites all residing on the core and P1 domains (Fig. 1 B and C). The finding that high-efficiency crosslinking sites for client uOMPs map to the SurA P1 and core domains is consistent with previous experiments that found that removal of the P2 domain did not affect the binding affinity of uOmpA171 to SurA (22). In contrast, the nonclient uOmpLA showed low crosslinking efficiencies; indeed, only half of the SurApAF variants could form crosslinks with uOmpLA at all (SI Appendix, Fig. S3 and Table S1). In addition to the high-efficiency crosslinking sites on SurA for cognate client uOMPs, we observed lower levels of crosslinking to client uOMPs at other pAF sites across the surface of SurA. The observed differences in crosslinking efficiencies between client and nonclient uOMPs indicate that SurA is inherently able to distinguish client uOMP sequences in solution without the aid of other chaperones.

SurA Binds uOMPs in a Groove between the Core and P1 Domains.

We sought to identify the uOMP binding site on SurA by visualizing the high-efficiency pAF crosslinking sites on known conformations of SurA (SI Appendix, Table S2) (37, 39). This analysis revealed that residues colocalized around a groove that forms between the core and P1 domains in the open conformation (Fig. 1D and SI Appendix, Figs. S4 and S5). In this conformation, both of the PPIase domains are structurally isolated from the core domain (shown in Fig. 1 A, B, and D).

The uOMP-binding groove is large enough (∼25 × 25 × 25 Å) to shield from water the entire length of either a transmembrane β-strand or β-hairpin of a uOMP (SI Appendix, Fig. S5A). The walls of the groove are formed by the core and P1 domains, which provide hydrophobic patches surrounded by weakly positively charged regions. The base of the groove contains a long hydrophobic stretch (30 Å) and is more positively charged than the walls. Interestingly, the regions of the core and P1 domains outside of the groove are highly negatively charged. The separation of charges on SurA could allow electrostatics to play a role in driving uOMP binding to the groove (SI Appendix, Fig. S5B). In sum, the SurA groove possesses a hybrid chemical nature and size well-suited to accommodate the alternating hydrophobic–hydrophilic patterning of uOMP transmembrane domains.

SurA Solubilizes uOmpA171 in an Expanded Conformation.

uOMPs are expected to exist in a relatively collapsed, molten globule state in the absence of chaperones (50). This collapsed conformation is maintained when uOmpA171 is bound by the other major chaperone in the uOMP biogenesis pathway, Skp (60, 61). To determine whether the overall size and shape of a uOMP changes when bound to SurA, we measured the hydrodynamic properties of the complex using SANS. SANS reports directly on the radius of gyration (RG) and the maximum end-to-end distance (DMax) of macromolecules. Moreover, the sample and buffer conditions can be manipulated in a SANS experiment to visualize a selected component within a complex.

We capitalized on this selective contrast feature of SANS and collected the scattering profile of a photo-crosslinked complex composed of protonated SurA105,pAF and perdeuterated uOmpA171 in 30% D2O (Fig. 2A). In this experiment, SurA contributes a minor fraction to the scattering contrast (SI Appendix, Fig. S6), and the scattering intensity is primarily contributed by uOmpA171. Guinier and P(r) analyses of data collected in this condition revealed that the complex has an RG value of 45 ± 3 Å and a DMax of 150 ± 10 Å (Fig. 2 B and C and SI Appendix, Tables S3 and S4). These sizes far exceed the expected RG and DMax calculated from the structure of apo-SurA (RG = 35 Å; DMax = 105 Å). Previous experiments also show that apo-SurA is not denatured by D2O (39). We therefore conclude that the large complex size observed arises from an expanded state of uOmpA171 while in complex with SurA.

Fig. 2.

Fig. 2.

SANS of a SurA105,pAF–uOmpA171 complex reveals an expanded uOmpA171. (A) Raw scattering profile of protonated-SurA105,pAF photo-crosslinked to deuterated-uOmpA171 in 30% D2O buffer is shown in green. Error bars represent the SEM with respect to the number of pixels used in the data averaging. (B) Linear fit of the Guinier region of the SANS profile determines the RG of the complex to be 45 ± 3 Å. (C) P(r) distribution function; DMax is estimated to be 150 ± 10 Å.

To understand the extent to which SurA expands uOmpA171 relative to the inherent, unbound uOmpA171 molten-globule state, we estimated the intrinsic RG and DMax of unfolded OmpA171. It is impossible to directly measure these parameters with scattering experiments because uOMPs aggregate at the required protein concentrations. However, a complementary hydrodynamic parameter of uOmpA171, the sedimentation coefficient, s, has been previously reported (s = 1.65 Svedbergs) (62). We connected RG, DMax, and s-value using a HullRad-based analysis of atomic models of uOmpA171 (63). A series of structural models of unfolded OmpA171 were created, and the average RG and DMax of uOmpA171 models that agree with the experimental s-value were 25 ± 1 Å and 82.5 ± 9 Å, respectively (SI Appendix, Figs. S7 and S8) (error is estimated from SDs). Thus, the RG and DMax of uOmpA171 are both approximately doubled when it is in complex with SurA. In sum, our pAF crosslinking and SANS data support a model where client uOMPs are expanded by SurA: a portion of the client uOMP is bound within the SurA groove, and the remainder of the uOMP is poised to sample transient interactions broadly across the SurA surface.

SurA Preferentially Interacts with Specific Segments on Client uOMPs.

The expansion of uOMPs by SurA raises the question of where and how they interact with the SurA groove. To further define the molecular basis of the SurA•uOMP interaction, we used photo-crosslinking mass spectrometry (pXL-MS) to identify the segments on uOMPs that crosslinked to the high efficiency SurApAF variants. We identified multiple SurA-binding segments on each client uOMP according to the following criteria.

The eight high-efficiency SurApAF variants were crosslinked to uOmpA171 and uOmpX and subjected to proteolysis with either trypsin only or trypsin and GluC in serial (SI Appendix). The resulting peptides were analyzed by liquid chromatography tandem mass spectrometry (LC-MS/MS), and crosslinked peptides were identified (with false discovery rate [FDR] < 0.01) using the MeroX v2.0 software package (SI Appendix) (64). Summary data of all pXL-MS experiments are given in SI Appendix, Table S5, and summary data of all peptide spectrum matches (PSMs) from these pXL-MS experiments are provided as Datasets S1 and S2.

Fig. 3A shows the crosslinking pattern identified for both uOmpA171 and uOmpX for each high efficiency SurApAF variant. We hypothesized that uOMP residues which repeatedly crosslink to SurApAF variants (>50%) delineate preferred uOMP binding segments. This strategy was necessary because the high reactivity of the nitrene group formed upon photolysis of pAF combined with the difficulty of determining the relative abundance of various crosslinked peptides made it impossible to use the crosslink sites from any individual SurApAF variant to distinguish preferred binding segments.

Fig. 3.

Fig. 3.

Photo-crosslinking mass spectrometry (pXL-MS) identifies segments on client uOMPs that bind SurA. (A) The crosslinking patterns for eight high-efficiency SurApAF variants are shown to two uOMP clients (uOmpA171 and uOmpX). Constructs that place pAF on the core domain are colored gray (top register), and constructs that place pAF on the P1 domain are colored blue (second register). The crosslinking heat map depicts the frequency a given residue on a client uOMP crosslinks to pAF in eight separate crosslinking experiments (darker magenta indicates residue is crosslinked more often). Binding segments are demarcated with a colored bar above the heat map and a label (S1 to 6 or S1 to 4). The bottom register shows results from two negative control studies using SurA26,pAF and SurA422,pAF (see main text for explanation). Only one uOmpA171 crosslinked peptide was found for each of these constructs while uOmpX did not crosslink at all. (B) An expanded uOmpA171 model with hydrodynamic properties consistent with the contrast-matched SANS experiment is shown as a schematic with the SurA-binding segments colored as in A. Two different segments (S2, left structure, o1s022; and S6, right structure, o1s021) are shown bound to SurA (shown in gray with a surface representation), suggesting that more than one copy of SurA could bind a single copy of uOmpA171 with minimal steric clash.

Using this criterion, we identified six SurA-binding segments on uOmpA171 (residues 1 to 21, 51 to 61, 84 to 86, 95 to 104, 112 to 113, and 130 to 131) and four SurA-binding segments on uOmpX (residues 29 to 36, 42 to 48, 64 to 73, and 81 to 89) as shown in Fig. 3A. The identified uOMP binding segments vary in length and location between the client uOMPs and crosslink to residues on both the core and P1 domains of SurA. The sequences of these SurA-binding segments are unusually enriched in tyrosine residues (10 of the 13 tyrosines on uOmpA171 appear in segments; P = 0.003 by χ2 test). Indeed, SurA has been shown to preferentially bind to peptides with high aromatic content, affirming our criteria for defining uOMP segments (30). Serendipitously, in OmpA, many of these tyrosines are highly conserved according to the Pfam database (Pfam ID: 01389), perhaps indicating importance for these residues in OmpA biogenesis (65).

To validate the importance of the SurA groove as the uOMP binding site, we performed two controls. In the first, we carried out pXL-MS on SurA422,pAF, which places the pAF away from the groove on the opposite side of the core domain. SurA422,pAF only crosslinks to a single site on uOmpA171 and did not crosslink to uOmpX at all, demonstrating a preference of uOMP interactions with the SurA groove (Fig. 3A). Secondly, we found a similarly small number of crosslinks upon mutation of a highly conserved residue in the construct SurA26,pAF that also resides away from the groove. Taken together, these experiments show that binding segments on uOMPs selectively distinguish and interact with the SurA groove.

Fig. 3B shows a structural model of uOmpA171 in an expanded state, with a DMax equal to the experimentally determined size of uOmpA171 when bound to SurA. Each of the putative binding segments is highlighted with the same colors used in Fig. 3A. Two possible SurAuOmpA171 complexes are shown, with SurA bound to the second (Fig. 3B, left structure) and last two segments (Fig. 3B, right structure) of uOmpA171. The presence of multiple SurA-binding segments on uOmpA171, along with its expanded size, could allow for more than one copy of SurA to simultaneously bind to different segments of a single uOmpA171 (Fig. 3B), as further supported by the presence of higher molecular weight bands in SDS/PAGE of some crosslinked SurApAF variants (SI Appendix, Fig. S2).

Modeling the Structural Features of SurA•uOmpA171.

Our SDS/PAGE (Fig. 1B and SI Appendix, Fig. S2), SANS (Fig. 2), and pXL-MS (Fig. 3) experiments support a mechanism in which SurA binds a defined client uOMP segment in the SurA groove. The remainder of the uOMP is greatly expanded and presumed to be dynamic. To visualize this binding mode in more detail, we built 23 models of uOmpA171 bound to SurA using our experimental findings as restraints.

SI Appendix, Figs. S9 and S10 provides flowcharts describing the process by which these models were generated and where each piece of experimental information was included; computational modeling is described further in SI Appendix. In essence, we docked the binding segments of uOmpA171 identified by pXL-MS to the groove of SurA using distance restraints generated by HADDOCK (66). The uOmpA171 components of these models were then expanded to be compatible with the SANS data (SI Appendix, Fig. S11 A and B).

The Hill coefficient reported for SurA binding uOmpA171 is greater than 1, indicating more than one copy of SurA can interact with uOmpA171 at a time (23). This multiplicity is also consistent with our finding of higher molecular weight bands in SurApAF SDS/PAGE experiments. Accordingly, we also created 17 models with additional SurA protomers docked to the expanded uOmpA171 (SI Appendix, Fig. S11 CE). Hydrodynamic parameters of each of the 40 structural models created are tabulated in SI Appendix, Table S6.

Chemical Crosslinking Validates Features of SurA•uOmpA171 Models and Reveals Distinct Binding Modes.

To validate structural features of the SurA•uOmpA171 sparse ensemble of structural models, we performed XL-MS with the chemical crosslinker disuccinimidyl dibutyric urea (DSBU) on wild-type (WT) SurA and our client uOMPs. In total, we identified 46 unique DSBU crosslinks between SurA and uOmpA171 and 17 unique DSBU crosslinks between SurA and uOmpX (SI Appendix, Fig. S12 and Table S5 and Datasets S3–S5).

To ascertain underlying similarities in our structural models, we performed spectral biclustering on a matrix of all solvent-accessible surface distances (SASDs) (calculated using JWalk) for the 46 identified crosslinks in all 23 structural models of SurA•uOmpA171 (SI Appendix, Fig. S13 shows this analysis, and Dataset S6 provides all SASDs and their associated scores) (6769). Due to the conformational heterogeneity and multiplicity of the SurA•uOmpA171 sparse ensemble, no single structural model captured all of the DSBU crosslinks. However, three distinct SurA•uOmpA171 binding modes emerged from this analysis, which are each explained by a unique subset of the identified crosslinks.

Fig. 4A shows an example of the first binding mode, which is found in seven of our SurA•uOmpA171 models, wherein segment 1 is bound in the groove, and the remainder of uOmpA171 is projecting away from SurA. The second binding mode, shown in Fig. 4B, is present in five SurA•uOmpA171 models and is similar to the first binding mode one except segment 2 is bound in the groove. Seven members of the sparse ensemble evinced a more complex topology in which the uOMP threads through the groove several times, defining a third binding mode (Fig. 4C). Similar to the first binding mode, segment 1 is bound in the groove, but, in this latter mode, segments 3, 4, and 5 now make extensive contacts with the groove and P1 on a “second pass.” Together, these three binding modes of the SurA•uOmpA171 complex cover 75% (34 of 46) (SI Appendix, Fig. S13) of the identified DSBU crosslinks and help explain why so many regions of uOmpA171 can crosslink with the SurA groove (Fig. 3).

Fig. 4.

Fig. 4.

Structural models of three SurA•uOmpA171 binding modes validated by XL-MS and SANS. SurA is represented as a surface (colored as in Fig. 1A), and uOmpA171 is represented as a tube (with binding segments demarcated by color as in Fig. 3). DSBU crosslink sites are represented as spheres, with crosslinks depicted as SASDs created by Jwalk. Crosslinks captured in each model are colored black (see SI Appendix, Fig. S13 for details). (A) A representative structural model of the first binding mode (o1s016), supported by a cluster of 10 crosslinks primarily between S1 (pink) and the core and P2 domains of SurA. (B) A representative structural model of the second binding mode (o1s010), supported by a cluster of nine crosslinks primarily between S2 (cyan) and surrounding regions of uOmpA171 and the core and P1 domains of SurA. (C) Representative structural model of the third binding mode (o1s009), supported by 15 crosslinks between segment 1 (pink) and segments 3, 4, and 5 (orange) primarily to the core domain of SurA. (D) A representative structure of two SurA protomers bound to uOmpA171 (o2s006) wherein one copy of SurA binds segment 1, and another copy binds segments 3, 4, and 5.

As described above, we constructed (SurA)n•uOmpA171 models with higher order stoichiometries (where n = {2, 3, 4}). These models provide an additional explanation for the complex DSBU crosslinking pattern between uOmpA171 and SurA. Fig. 4D shows how a single uOmpA171 can distribute these binding modes across more than one copy of SurA, instead of threading itself through a single copy of SurA multiple times—accommodating the same clusters of crosslinks. Moreover, inclusion of models with higher order stoichiometries increases coverage to 89% of identified DSBU crosslinks (Dataset S6).

Finally, as a critical control to confirm the SurA groove as the primary binding site for uOMP substrates, we performed DSBU crosslinking experiments between uOmpA171 and the “locked-closed” SurA variant (P61C/A218C) previously described by Silhavy and coworkers (38). In this variant, the open conformation of SurA is inaccessible, and cells show increased sensitivity to envelope stressors in vivo. We observed a drastic reduction in the number of “locked-closed” SurA–uOmpA171 interprotein crosslinks compared to WT SurA (7 vs. 46) (SI Appendix, Fig. S12 and Datasets S3 and S5). This finding implies that the dense crosslinking patterns revealed by XL-MS depend on the formation of the SurA groove, and not from contacts made outside of the groove.

SANS Validates and Quantifies XL-MS–Based Binding Modes.

To test which SurA•uOmpA171 models are representative of the conformational ensemble in solution, we compared them to an independent SANS profile of SurA105,pAF-uOmpA171 collected in 0% D2O (SI Appendix, Fig. S14). In this particular condition, protonated SurA and perdeuterated uOmpA171 contribute equally to scattering (SI Appendix, Fig. S6). We calculated the expected scattering profile that would arise under these experimental conditions for each of the 40 SurA•uOmpA171 models using the software package SASSIE (70). In addition to the models of the SurA•uOmpA171 complex, we included multiple models of apo-SurA in varying conformations as we were unable to completely purify the crosslinked complex (SI Appendix, Fig. S15). In agreement with the DSBU crosslinking, we found that no single model, or pairs of models, recapitulated the experimental scattering profile (reduced χ2 < 1.05) (71).

Linear combinations of the scattering profiles from three structural models were able to describe the SANS dataset. In total, we sampled over 1 million combinations of triplets of models and found 35 combinations whose simulated SANS profiles produced reduced χ2 values less than 1.05 with respect to the experimentally observed 0% D2O SANS profile. Each accepted triplet contained at least one model of noncrosslinked SurA and one SurA•uOmpA171 complex (SI Appendix, Table S7). The three models most likely to be included in an accepted combination arise from the three distinct binding modes defined by XL-MS and are shown in Fig. 4 AC with their associated crosslinks. In addition, the linear combinations identify several models with higher order stoichiometries as depicted in Fig. 4D.

The sparse ensemble illustrating the main structural features identified by our experiments is depicted in Fig. 5 by an overlay of SurA•uOmpA171 models (the population of each model in the ensemble is listed in SI Appendix, Table S8). We note that this collection of conformations captures all known experimental data on SurA•uOMP complexes: including uOMP binding to the SurA groove (Fig. 1), the Hill coefficient that is slightly greater than 1, the expansion of uOMPs by SurA (Fig. 2), pXL-MS identification of specific binding segments (Fig. 3), and the independent validation of binding modes by SANS and XL-MS (Figs. 4 and 5) (22, 37, 38, 49). This sparse ensemble of models of the SurA•uOmpA171 complex provides a chemically reasonable and minimalist set of structures that could exist in the full conformational ensemble of the complex in solution. Due to limitations in the resolution of the data, additional conformations that fit the data likely exist.

Fig. 5.

Fig. 5.

SurA•uOmpA171 ensemble as defined by experimental restraints reveals the uOmpA171 conformational landscape. The 21 SurA•uOmpA171 structural models that were part of triplets of linearly weighted models that fit the 0% D2O SANS data are overlaid aligned to SurA. SurA is in the open conformation and shown with a surface representation with domains colored as in Fig. 1A. uOmpA171 models are shown with a schematic representation and have SurA-binding segments, as defined by XL-MS, colored as in Fig. 3. Higher order stoichiometries are found in the ensemble, with additional copies of SurA shown as transparent, gray structures. The diversity of uOmpA171 conformations that are shown in this ensemble highlights the conformational dynamics accessible to client uOMPs when bound to SurA.

Discussion

The periplasmic chaperone network is integral for E. coli outer membrane protein biogenesis. SurA plays several important roles in the uOMP biogenesis pathway: It must 1) recognize uOMP clients before they aggregate; 2) maintain them in a soluble form in the periplasm; and 3) mediate a hand off to the BAM complex. In this study, we have utilized an integrative/hybrid structural biology approach that combines multiple crosslinking and scattering techniques to generate restraints used to build a representative ensemble. This ensemble captures key structural features of SurA in complex with its client uOmpA171.

The model-independent Guinier analysis of the contrast-matched SANS experiments reveals that SurA performs its functions by dramatically expanding the SurA–uOMP complex in a mechanism reminiscent of trigger factor, a structural homolog to SurA (72). We observe a primary uOMP interaction in the SurA groove, located between the core and P1 domains, which recapitulates recently published findings (37). The remainder of the unfolded uOmpA171 chain that is not occupying the groove must assume an elongated conformation to be consistent with these SANS data. In contrast, a covalently “locked-closed” variant of SurA is unable to efficiently interact with uOmpA171, consistent with the reduced functionality of this variant in vivo. All together, these results suggest uOMP binding to the SurA groove results in uOMP expansion relative to its compact native state, as exemplified in Figs. 35.

This expansion of uOMPs is distinctive from a recently published model of the SurA–uOmpX complex built from crosslinking data alone (37). In that model, a single SurA completely encapsulates a globular uOMP, and this structural interpretation is incongruous with our experimental findings as the present SANS data demonstrate that the uOmpA171 must instead be expanded. Although the reported crosslinking is consistent with our data, our approach also capitalized upon the usefulness of a hydrodynamic view of highly dynamic structures. Instead, our data for the SurA–uOmpA171 complex are more consistent with a dynamic conformational ensemble proposed for the SurA–FhuA complex based on NMR (42). The extent of expansion of unfolded FhuA is unresolved, however, because the hydrodynamic properties of this system have not yet been established.

Unfolded OMP expansion mediated by a single SurA binding event is aided by the ability of additional copies of SurA to interact with distal binding segments on the uOMP (as shown in Figs. 3B and 4D). Expansion of uOMPs would help avoid steric clashes between different copies of SurA simultaneously interacting with an uOMP client. For the small, eight-stranded uOMPs investigated here, higher order stoichiometries represent minor populations in the ensemble. It is reasonable to speculate that the length of a client uOMP could dictate the binding stoichiometry of the SurA•uOMP complex as larger clients would ostensibly contain a greater number of SurA-binding segments. In accordance with this idea, gel filtration data suggest that the stoichiometry for the SurA–FhuA complex may be closer to 2:1 because FhuA is a much larger outer membrane protein (22 β-strands as compared to 8 for OmpA) (31, 42). Higher order stoichiometries could also be enhanced in the crowded periplasm where the excluded volume effect increases protein–protein interactions (73).

The initial finding of uOmpA171 expansion was surprising, especially because the other major periplasmic chaperone, Skp, encapsulates uOMPs in a collapsed state reminiscent of their intrinsic, unfolded conformation (42, 60). Given SurA interacts with uOMPs primarily through its groove, the persistent global expansion of the remainder of the client uOMP at first glance appears puzzling. We propose a kinetic trapping mechanism wherein binding and release of uOMP segments are fast relative to the collapse of the uOMP to its intrinsic molten globule state. Indeed, kinetic partitioning is a dominant organizing feature of the uOMP biogenesis chaperone network, and the interaction between SurA and uOMP happens on a very fast time scale (18, 43, 74). Rates of unfolded uOMP collapse are not known but may be relatively slow given the low overall hydrophobicity of transmembrane β-barrel primary sequences. Such a difference in the rates of uOMP intrinsic collapse versus expansion by SurA binding would provide a way to retain uOMPs in an expanded state through transient repeated associations with SurA protomers. This mechanism has the advantage of limiting the amount of SurA required to solubilize a client, thereby maximizing the reservoir of free SurA in the periplasm.

Fig. 6 highlights several biological implications of the features of our structural ensemble. We hypothesize that these SurA properties could explain its multifaceted roles in OMP biogenesis. Firstly, we expect that expansion of uOMPs would decrease unproductive intraprotein interactions and maintain the chain in a folding-competent, unfolded conformation (Fig. 6, step B). In this respect, SurA performs an orthogonal role to the other chaperones in the uOMP biogenesis network, which form cages around uOMPs to decrease interprotein interactions. Expansion may also mediate the formation of transient hetero-chaperone complexes in the periplasm where more than one chaperone is simultaneously bound to a uOMP (Fig. 6, steps C and D). As uOMPs are expected to undergo hundreds of individual binding and dissociation events while in the periplasm, a SurA-mediated hand off of expanded uOMPs between chaperones would allow for these events to occur while keeping the population of aggregation-prone, unbound uOMP low (18).

Fig. 6.

Fig. 6.

Implications of uOMP expansion in the periplasm. uOMPs are posttranslationally secreted through the Sec translocon (magenta), N- to C-terminally. (Step A) The emerging uOMP N terminus in the periplasm may be recognized by SurA. (Step B) After complete translocation into the periplasm, one or more SurA protomers bind specific segments on uOMP clients, solubilizing the uOMP in expanded conformations nearly the width of the periplasm. The expanded uOMP may also be able to form heterocomplexes with other chaperones in the OMP biogenesis pathway: Skp (Step C) and FkpA (Step D). The size of uOMPs bound to SurA is approximately double the size of uOMPs bound to Skp. Unfolded OmpA171 bound to Skp is shown as a gray surface representation in the Skp trimer located proximal to the translocon. (Step E) The extended, unbound C-terminal region of the SurA-bound uOMP is positioned to encounter the BAM complex, which recognizes the OMP β-signal and catalyzes uOMP folding into the outer membrane.

An intriguing outcome of our structural ensemble is the finding that SurA-binding segments of client uOMPs are located toward the N terminus (Fig. 3). Indeed, the three binding modes found for the SurA•uOmpA171 interaction are mediated by the two most N-terminal binding segments on uOmpA171. This suggests the possibility of an early encounter between SurA and client uOMPs in the periplasm (Fig. 6, step A). Accordingly, a recent, low resolution cryo-electron microscopy (cryo-EM) model places SurA near the translocon where it is well-positioned to bind emerging uOMP segments (75).

Conversely, there was a conspicuous absence of robust crosslinking for both client OMPs near their C termini. The apparent lack of SurA interaction sites in this uOMP region leaves the β-signal (Aro-X-Aro) free to interact with other members of the uOMP biogenesis pathway. The β-signal has been shown to play an important role in mediating efficient catalysis of uOMP folding by BAM both in vivo and in vitro (7678). As SurA is the only periplasmic chaperone that promotes the interaction between uOMPs and BAM, our data support a mechanistic hypothesis in which this region of uOMPs is free and flexible and effectively “cast” outward in a mechanism reminiscent of fly fishing to catch the BAM complex (Fig. 6, step E) (13, 79).

Even if it is transient, the formation of a SurA•uOMP•BAM ternary complex is enticing because it brings the uOMP close to both the BAM complex and the disrupted adjacent membrane, both of which accelerate uOMP folding (9, 80). The BAM complex has been proposed to template and insert uOMP β-hairpins as individual foldamers of OMPs. Notably, the SurA groove is large enough to accommodate a β-hairpin, which could potentially favor the preformation of this key structural element in a nascent uOMP. Moreover, this SurA-mediated β-hairpin formation mechanism could be easily adapted to larger clients with more transmembrane strands (and probably more SurA-binding segments), given the modular nature of the β-hairpin unit.

In this work, we highlight the utility and complementarity of photo-crosslinking and chemical crosslinking, neutron scattering, and mass spectrometry applied together. This combined approach was crucial because unfolded proteins present many challenges to conventional structural techniques due to their absence of regular secondary structure, their high conformational flexibility, and their propensity to aggregate. Our results illuminate a sparse ensemble of models that capture the key structural features defining how SurA promotes outer membrane protein biogenesis.

Materials and Methods

SurA Expression and Purification.

SI Appendix describes creation, expression, and purification of all SurA constructs used in this study.

pAF Crosslinking.

A total of 25 µmol⋅L−1 (µM) of each SurApAF variant was mixed with 5 µM uOMP, 20 mmol⋅L−1 (mM) Tris, and 1 mol⋅L−1 (M) urea, pH 8.0. uOMPs were expressed and purified as described previously (81). We chose these conditions because both SurA and uOmpA171 are monomeric and soluble at the listed protein and urea concentrations (39, 51). Mixtures were then irradiated with UV light (wavelength, λ = 254 nm) for 5 min using a Spectroline MiniMax UV Lamp (11-992-662; Fisher). Aliquots were taken for SDS/PAGE analysis both pre- and postexposure to UV light. These samples were subjected to electrophoresis using a 4 to 20% gradient precast gel (Mini-PROTEAN TGX; Bio-Rad) at a constant voltage of 200 V for 35 min at room temperature.

Using ImageJ, densitometry analysis on the loss of density of the uOmpA171 band was utilized to quantitate crosslinking efficiency. Crosslinking efficiency values were corrected for the amount of uOmpA171 band lost (∼20%) when mixed with WT SurA (not containing pAF). A representative SDS/PAGE gel for each SurApAF variant and uOmpA171 is shown in SI Appendix, Fig. S2. This same protocol was utilized to assess the crosslinking of SurApAF variants to uOmpX and uOmpLA.

SANS on Protonated-SurA/Perdeuterated-uOmpA171 Complex.

SurA105,pAF was crosslinked to deuterated-uOmpA171 as described above. Perdeuterated OmpA171 growth, expression, purification, and characterization are detailed in SI Appendix. This complex was further purified via size exclusion chromatography (SEC) (GE Superdex-200 10/300 GL; flow rate = 0.6 mL/min) in 20 mM Tris, 200 mM NaCl, pH 8.0 (GF buffer), and buffer was exchanged into either 0% or 30% D2O for SANS experiments (same buffer components as SEC) (SI Appendix, Fig. S15). We made three attempts to also collect scattering profiles in 80% and 98% D2O of this complex, but the I(0) values from Guinier fitting indicated that these samples contained aggregates. It is known that increased buffer concentrations of D2O may promote self-association and aggregation of particularly hydrophobic proteins (82).

All scattering experiments were collected at the National Institute of Standards and Technology Center for Neutron Research (Gaithersburg, MD) as previously described (60). More information on SANS data collection and analysis is found in SI Appendix.

XL-MS of SurA–uOMP Complexes.

SI Appendix describes the methods used to perform and analyze all XL-MS experiments, including the following: SurApAF–uOMP photo-crosslinked complexes, SurA–uOMP DSBU crosslinked complexes, and “locked-closed” SurA–uOmpA171 DSBU crosslinking complexes. This includes pAF and DSBU methods and data analysis protocols.

Structural Models of SurA.

Models of SurA were constructed based on crystal structures 1M5Y and 2PV3 (SI Appendix, Table S2). In the 1M5Y structure, the core and P1 domains are close together, but the P2 domain is extended. In the 2PV3 structure, the P1 domain is moved away from the core domain and rotated relative to 1M5Y, but the P2 domain is missing. Residue segments 20 to 34, 165 to 171, 387 to 394, and 428 to 430 were built into 1M5Y, and six histidine residues were added to the C terminus using Modeler to create the “P1 closed” form of SurA (83). For the “P2 closed” form of SurA, PyMOL was used to build the P2 domain from the P1 closed form into 2PV3 (84). The P2 domain was then moved into position against the groove formed by the core and P1 domains using NAMD as described below. The “open” SurA model has the core-P1 relative orientation from 2PV3 and the core-P2 relative orientation from 1M5Y. Domains were oriented in PyMOL, and linkage conformations were normalized using NAMD as described below. The “collapsed” SurA model has the core-P1 relative orientation from 1M5Y, and the P2 domain was moved into position against the core using NAMD as described below.

The P2 closed, open, and collapsed SurA models, initially constructed using PyMOL, were further manipulated to position the domains, remove Van der Waals clash, and relax unstructured linkage segments using NAMD with generalized Born implicit solvent electrostatics in the CHARMM22 force field (85). Domains were positioned with targeted distance restraints as implemented in the collective variable module in NAMD (86, 87). Typically, a harmonic potential was placed on the distance between the centers of mass of two groups of CA atoms with a force constant of 1.0 kcal/mol, and the force was applied for 50,000 to 150,000 steps. This in vacuo molecular relaxation and manipulation were carried out after 200 steps of energy minimization, with implicit solvent alpha cutoff = 12.0 Å, [ion] = 0.3 M, nonbonded cutoff = 14.0, switching starting at 13.0, and 2 fs time step. Langevin dynamics was used with a damping coefficient of 1 for temperature control (NVT: constant number of atoms, volume, and temperature). The domain–domain distances of SurA were monitored during simulation, and a structure was saved when target distances were obtained.

Structural Models of the SurA•uOmpA171 Complex.

Four extended uOmpA171 segments (residues 2 to 21, 54 to 73, 84 to 104, 112 to 132) that contain the six SurA-binding segments were independently submitted, along with the open SurA structural model to the protein–protein docking web server HADDOCK (66). These sequence segments were chosen to include those residues that were found to repeatedly crosslink to the high efficiency SurApAF variants. Active and passive residues for HADDOCK were chosen from SurA groove (SI Appendix, Fig. S9).

These docked oligopeptides were inspected using molecular graphics to obtain target distances for docking the full-length, unexpanded uOmpA171 models (s = 1.65) to the open form of SurA. Docking was accomplished in NAMD using the target distances from HADDOCK peptide docking as distance restraints in the collective variables module of NAMD as described above.

The uOmpA-open SurA models were further manipulated to increase the uOmpA DMax to the target of 150 Å that was determined by P(r) analysis of the SANS data. These expansions were accomplished using distance restraints and the collective variable module in NAMD. Short segments of each bound uOmpA that were furthest apart were identified, and the two groups of respective CA atoms were forced to a distance of ∼150 Å with a harmonic potential as described above. A second open SurA model was then docked to exposed, known binding segments (SI Appendix, Fig. S11) of the extended uOmpA. In three cases, a third open SurA was docked to remaining exposed known binding segments. One extended polypeptide of uOmpA was generated with a DMax ∼250 Å, and four open SurA models were docked to the four main segments on OmpA that displayed high efficiency crosslinking.

In all, 23 models containing one docked SurA, 13 models containing two docked SurA, 3 models containing three SurA, and 1 model containing four SurA were built. Physical dimensions of these models are listed in SI Appendix, Table S6. Values for RG and DMax were calculated using HullRad (63). All models contained CHARMM hydrogens and were used to calculate predicted SANS profiles using the SasCalc server (70).

Methods and information regarding the comparison of structural models to the 0% D2O SANS profiles performed to generate the ensemble of structures shown in Fig. 5 are found in detail in SI Appendix. Models included in the sparse conformational ensemble of SurA-uOmpA171 can be found at: https://github.com/KarenGFleming/SurAuOmpA.

Supplementary Material

Supplementary File
Supplementary File
pnas.2008175117.sd01.xlsx (128.3KB, xlsx)
Supplementary File
pnas.2008175117.sd02.xlsx (48.5KB, xlsx)
Supplementary File
pnas.2008175117.sd03.xlsx (48.6KB, xlsx)
Supplementary File
pnas.2008175117.sd04.xlsx (67.2KB, xlsx)
Supplementary File
pnas.2008175117.sd05.xlsx (66.4KB, xlsx)
Supplementary File

Acknowledgments

We thank the Johns Hopkins University Biomolecular NMR Center and the Center for Molecular Biophysics for providing facilities and resources. Access to NGB30 SANS was provided by the Center for High Resolution Neutron Scattering, a partnership between the National Institute of Standards and Technology and the NSF under Agreement DMR-1508249. We acknowledge the support of the National Institute of Standards and Technology, US Department of Commerce in providing the neutron research facilities used in this work. Certain commercial equipment, instruments, or materials (or suppliers, or software, ...) are identified in this paper to foster understanding. Such identification does not imply recommendation or endorsement by the National Institute of Standards and Technology, nor does it imply that the materials or equipment identified are necessarily the best available for the purpose. This work benefitted from CCP-SAS software developed through a joint Engineering and Physical Sciences Research Council (EP/K039121/1) and NSF (CHE-1265821) grant. This work was supported by NSF Grants MCB1412108 and MCB1931211 and NIH Grant R01 GM079440 (to K.G.F.). D.C.M., A.M.P., T.D., and H.J.L. were supported by NIH Training Grant T32 GM008403. A.M.P. was supported by NSF Grant DGE 1232825. We thank laboratory members for helpful discussions.

Footnotes

The authors declare no competing interest.

This article is a PNAS Direct Submission.

This article contains supporting information online at https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.2008175117/-/DCSupplemental.

Data Availability.

All raw data and detailed protocols, including gel images, SANS profiles, and SurA–uOmpA171 models, are available at https://github.com/KarenGFleming/SurAuOmpA. SI Appendix includes detailed protocols and raw data associated with XL-MS experiments. All raw and analyzed mass spectra are available on ProteomeXchange under identifiers PXD021870 and PXD021872.

Change History

July 8, 2021: The Acknowledgments have been updated.

References

  • 1.Chiti F., Dobson C. M., Protein misfolding, amyloid formation, and human disease: A summary of progress over the last decade. Annu. Rev. Biochem. 86, 27–68 (2017). [DOI] [PubMed] [Google Scholar]
  • 2.Dobson C. M., Principles of Protein Folding, Misfolding and Aggregation in Seminars in Cell and Developmental Biology, (Elsevier Ltd, 2004). [DOI] [PubMed] [Google Scholar]
  • 3.Barral J. M., Broadley S. A., Schaffar G., Hartl F. U., Roles of molecular chaperones in protein misfolding diseases. Semin. Cell Dev. Biol. 15, 17–29 (2004). [DOI] [PubMed] [Google Scholar]
  • 4.Hartl F. U., Hayer-Hartl M., Protein folding. Molecular chaperones in the cytosol: From nascent chain to folded protein. Science 295, 1852–1858 (2002). [DOI] [PubMed] [Google Scholar]
  • 5.Kim Y. E., Hipp M. S., Bracher A., Hayer-Hartl M., Hartl F. U., Molecular chaperone functions in protein folding and proteostasis. Annu. Rev. Biochem. 82, 323–355 (2013). [DOI] [PubMed] [Google Scholar]
  • 6.Saibil H., Chaperone machines for protein folding, unfolding and disaggregation. Nat. Rev. Mol. Cell Biol. 14, 630–642 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Hartl F. U., Molecular chaperones in cellular protein folding. Nature 381, 571–579 (1996). [DOI] [PubMed] [Google Scholar]
  • 8.Hartl F. U., Bracher A., Hayer-Hartl M., Molecular chaperones in protein folding and proteostasis. Nature 475, 324–332 (2011). [DOI] [PubMed] [Google Scholar]
  • 9.Plummer A. M., Fleming K. G., From chaperones to the membrane with a BAM!. Trends Biochem. Sci. 41, 872–882 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Chaturvedi D., Mahalakshmi R., Transmembrane β-barrels: Evolution, folding and energetics. Biochim. Biophys. Acta Biomembr. 1859, 2467–2482 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Ulrich T., Rapaport D., Biogenesis of beta-barrel proteins in evolutionary context. Int. J. Med. Microbiol. 305, 259–264 (2015). [DOI] [PubMed] [Google Scholar]
  • 12.Herrmann J. M., Riemer J., Three approaches to one problem: Protein folding in the periplasm, the endoplasmic reticulum, and the intermembrane space. Antioxid. Redox Signal. 21, 438–456 (2014). [DOI] [PubMed] [Google Scholar]
  • 13.Wang Y.et al., A supercomplex spanning the inner and outer membranes mediates the biogenesis of β-barrel outer membrane proteins in bacteria. J. Biol. Chem. 291, 16720–16729 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Koebnik R., Locher K. P., Van Gelder P., Structure and function of bacterial outer membrane proteins: Barrels in a nutshell. Mol. Microbiol. 37, 239–253 (2000). [DOI] [PubMed] [Google Scholar]
  • 15.Luther A.et al., Chimeric peptidomimetic antibiotics against Gram-negative bacteria. Nature 576, 452–458 (2019). [DOI] [PubMed] [Google Scholar]
  • 16.Hart E. M.et al., A small-molecule inhibitor of BamA impervious to efflux and the outer membrane permeability barrier. Proc. Natl. Acad. Sci. U.S.A. 116, 21748–21757 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Imai Y.et al., A new antibiotic selectively kills Gram-negative pathogens. Nature 576, 459–464 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Costello S. M., Plummer A. M., Fleming P. J., Fleming K. G., Dynamic periplasmic chaperone reservoir facilitates biogenesis of outer membrane proteins. Proc. Natl. Acad. Sci. U.S.A. 113, E4794–E4800 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Sklar J. G., Wu T., Kahne D., Silhavy T. J., Defining the roles of the periplasmic chaperones SurA, Skp, and DegP in Escherichia coli. Genes Dev. 21, 2473–2484 (2007). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Rizzitello A. E., Harper J. R., Silhavy T. J., Genetic evidence for parallel pathways of chaperone activity in the periplasm of Escherichia coli. J. Bacteriol. 183, 6794–6800 (2001). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Malinverni J. C., Silhavy T. J., Assembly of outer membrane β-Barrel proteins: The Bam complex. Ecosal Plus 4, 1–33 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Humes J. R.et al., The role of SurA PPIase domains in preventing aggregation of the outer-membrane proteins tOmpA and OmpT. J. Mol. Biol. 431, 1267–1283 (2019). [DOI] [PubMed] [Google Scholar]
  • 23.Schiffrin B.et al., Effects of periplasmic chaperones and membrane thickness on BamA-catalyzed outer-membrane protein folding. J. Mol. Biol. 429, 3776–3792 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Mas G., Hiller S., Conformational plasticity of molecular chaperones involved in periplasmic and outer membrane protein folding. FEMS Microbiol. Lett. 365, 1–9 (2018). [DOI] [PubMed] [Google Scholar]
  • 25.Mas G., Thoma J., Hiller S., The periplasmic chaperones Skp and SurA. Subcell. Biochem. 92, 169–186 (2019). [DOI] [PubMed] [Google Scholar]
  • 26.Chum A. P., Shoemaker S. R., Fleming P. J., Fleming K. G., Plasticity and transient binding are key ingredients of the periplasmic chaperone network. Protein Sci. 28, 1340–1349 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Stull F., Betton J.-M., Bardwell J. C. A., Periplasmic chaperones and prolyl isomerases. Ecosal Plus 8, 1–16 (2018). [DOI] [PubMed] [Google Scholar]
  • 28.Denoncin K., Schwalm J., Vertommen D., Silhavy T. J., Collet J.-F., Dissecting the Escherichia coli periplasmic chaperone network using differential proteomics. Proteomics 12, 1391–1401 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Lazar S. W., Almirón M., Tormo A., Kolter R., Role of the Escherichia coli SurA protein in stationary-phase survival. J. Bacteriol. 180, 5704–5711 (1998). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Hennecke G., Nolte J., Volkmer-Engert R., Schneider-Mergener J., Behrens S., The periplasmic chaperone SurA exploits two features characteristic of integral outer membrane proteins for selective substrate recognition. J. Biol. Chem. 280, 23540–23548 (2005). [DOI] [PubMed] [Google Scholar]
  • 31.Vertommen D., Ruiz N., Leverrier P., Silhavy T. J., Collet J. F., Characterization of the role of the Escherichia coli periplasmic chaperone SurA using differential proteomics. Proteomics 9, 2432–2443 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Rollauer S. E., Sooreshjani M. A., Noinaj N., Buchanan S. K., Outer membrane protein biogenesis in Gram-negative bacteria. Philos. Trans. R. Soc. Lond. B Biol. Sci. 370, 1–10 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Schiffrin B.et al., Skp is a multivalent chaperone of outer-membrane proteins. Nat. Struct. Mol. Biol. 23, 786–793 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Krojer T.et al., Structural basis for the regulated protease and chaperone function of DegP. Nature 453, 885–890 (2008). [DOI] [PubMed] [Google Scholar]
  • 35.Sandlin C. W., Zaccai N. R., Fleming K. G., Skp trimer formation is insensitive to salts in the physiological range. Biochemistry 54, 7059–7062 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Bitto E., McKay D. B., Crystallographic structure of SurA, a molecular chaperone that facilitates folding of outer membrane porins. Structure 10, 1489–1498 (2002). [DOI] [PubMed] [Google Scholar]
  • 37.Calabrese A. N.et al., Inter-domain dynamics in the chaperone SurA and multi-site binding to its outer membrane protein clients. Nat. Commun. 11, 2155 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Soltes G. R., Schwalm J., Ricci D. P., Silhavy T. J., The activity of Escherichia coli chaperone SurA is regulated by conformational changes involving a parvulin domain. J. Bacteriol. 198, 921–929 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Marx D. C., Leblanc M. J., Plummer A. M., Krueger S., Fleming K. G., Domain interactions determine the conformational ensemble of the periplasmic chaperone SurA. Protein Sci., 10.1002/pro.3924 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Webb H. M., Ruddock L. W., Marchant R. J., Jonas K., Klappa P., Interaction of the periplasmic peptidylprolyl cis-trans isomerase SurA with model peptides. The N-terminal region of SurA id essential and sufficient for peptide binding. J. Biol. Chem. 276, 45622–45627 (2001). [DOI] [PubMed] [Google Scholar]
  • 41.Behrens S., Maier R., de Cock H., Schmid F. X., Gross C. A., The SurA periplasmic PPIase lacking its parvulin domains functions in vivo and has chaperone activity. EMBO J. 20, 285–294 (2001). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Thoma J., Burmann B. M., Hiller S., Müller D. J., Impact of holdase chaperones Skp and SurA on the folding of β-barrel outer-membrane proteins. Nat. Struct. Mol. Biol. 22, 795–802 (2015). [DOI] [PubMed] [Google Scholar]
  • 43.Li G.et al., Single-Molecule detection reveals different roles of Skp and SurA as chaperones. ACS Chem. Biol. 13, 1082–1089 (2018). [DOI] [PubMed] [Google Scholar]
  • 44.Bell E. W., Zheng E. J., Ryno L. M., Identification of inhibitors of the E. coli chaperone SurA using in silico and in vitro techniques. Bioorg. Med. Chem. Lett. 28, 3540–3548 (2018). [DOI] [PubMed] [Google Scholar]
  • 45.Bitto E., McKay D. B., Binding of phage-display-selected peptides to the periplasmic chaperone protein SurA mimics binding of unfolded outer membrane proteins. FEBS Lett. 568, 94–98 (2004). [DOI] [PubMed] [Google Scholar]
  • 46.Stymest K. H., Klappa P., The periplasmic peptidyl prolyl cis-trans isomerases PpiD and SurA have partially overlapping substrate specificities. FEBS J. 275, 3470–3479 (2008). [DOI] [PubMed] [Google Scholar]
  • 47.Bitto E., McKay D. B., The periplasmic molecular chaperone protein SurA binds a peptide motif that is characteristic of integral outer membrane proteins. J. Biol. Chem. 278, 49316–49322 (2003). [DOI] [PubMed] [Google Scholar]
  • 48.Chai Q.et al., Diverse sequences are functional at the C-terminus of the E. coli periplasmic chaperone SurA. Protein Eng. Des. Sel. 27, 111–116 (2014). [DOI] [PubMed] [Google Scholar]
  • 49.Thoma J., Burmann B. M., Hiller S., Müller D. J., Impact of holdase chaperones Skp and SurA on the folding of β-barrel outer-membrane proteins. Nat. Struct. Mol. Biol. 22, 795–802 (2015). [DOI] [PubMed] [Google Scholar]
  • 50.Krainer G.et al., Slow interconversion in a heterogeneous unfolded-state ensemble of outer-membrane phospholipase A. Biophys J. 113, 1280–1289 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Ebie Tan A., Burgess N. K., DeAndrade D. S., Marold J. D., Fleming K. G., Self-association of unfolded outer membrane proteins. Macromol. Biosci. 10, 763–767 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Danoff E. J., Fleming K. G., Aqueous, Unfolded OmpA forms amyloid-like fibrils upon self-association. PLoS One 10, e0132301 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Wang L., Brock A., Herberich B., Schultz P. G., Expanding the genetic code of Escherichia coli. Science 292, 498–500 (2001). [DOI] [PubMed] [Google Scholar]
  • 54.Hagan B., Staros J. V., Azides and Nitrenes: Reactivity and Utility, (Academic Press, 1984). [Google Scholar]
  • 55.Reddington S. C.et al., Different photochemical events of a genetically encoded phenyl azide define and modulate GFP fluorescence. Angew. Chem. Int. Ed. Engl. 52, 5974–5977 (2013). [DOI] [PubMed] [Google Scholar]
  • 56.Willkomm S., Zander A., Grohmann D., “Site-specific fluorescent labeling of argonaute for FRET-based bio-assays” in Methods in Molecular Biology, Schmidt M., Ed., (Humana Press Inc., 2017), pp. 291–304. [DOI] [PubMed] [Google Scholar]
  • 57.Chin J. W.et al., Addition of p-azido-L-phenylalanine to the genetic code of Escherichia coli. J. Am. Chem. Soc. 124, 9026–9027 (2002). [DOI] [PubMed] [Google Scholar]
  • 58.Stengel F.et al., Quaternary dynamics and plasticity underlie small heat shock protein chaperone function. Proc. Natl. Acad. Sci. U.S.A. 107, 2007–2012 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Schneider C. A., Rasband W. S., Eliceiri K. W., NIH image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671–675 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Zaccai N. R.et al., “Deuterium labeling together with contrast variation small-angle neutron scattering suggests how Skp captures and releases unfolded outer membrane proteins” in Methods in Enzymology, Kelman Z., Ed., (Academic Press Inc., 2016), pp. 159–210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Burmann B. M., Wang C., Hiller S., Conformation and dynamics of the periplasmic membrane-protein-chaperone complexes OmpX-Skp and tOmpA-Skp. Nat. Struct. Mol. Biol. 20, 1265–1272 (2013). [DOI] [PubMed] [Google Scholar]
  • 62.Danoff E. J., Fleming K. G., The soluble, periplasmic domain of OmpA folds as an independent unit and displays chaperone activity by reducing the self-association propensity of the unfolded OmpA transmembrane β-barrel. Biophys. Chem. 159, 194–204 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Fleming P. J., Fleming K. G., HullRad: Fast calculations of folded and disordered protein and nucleic acid hydrodynamic properties. Biophys. J. 114, 856–869 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Götze M.et al., Automated assignment of MS/MS cleavable cross-links in protein 3D-structure analysis. J. Am. Soc. Mass Spectrom. 26, 83–97 (2015). [DOI] [PubMed] [Google Scholar]
  • 65.El-Gebali S.et al., The Pfam protein families database in 2019. Nucleic Acids Res. 47, D427–D432 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.van Zundert G. C. P.et al., The HADDOCK2.2 web server: User-friendly integrative modeling of biomolecular complexes. J. Mol. Biol. 428, 720–725 (2016). [DOI] [PubMed] [Google Scholar]
  • 67.Matthew Allen Bullock J., Schwab J., Thalassinos K., Topf M., The importance of non-accessible crosslinks and solvent accessible surface distance in modeling proteins with restraints from crosslinking mass spectrometry. Mol. Cell. Proteomics 15, 2491–2500 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Bullock J. M. A., Thalassinos K., Topf M., Jwalk and MNXL web server: Model validation using restraints from crosslinking mass spectrometry. Bioinformatics 34, 3584–3585 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Pedregosa F.et al., Scikit-learn: Machine learning in Python. J. Mach. Learn. Res. 12, 2825–2830 (2011). [Google Scholar]
  • 70.Curtis J. E., Raghunandan S., Nanda H., Krueger S., SASSIE: A program to study intrinsically disordered biological molecules and macromolecular ensembles using experimental scattering restraints. Comput. Phys. Commun. 183, 382–389 (2012). [Google Scholar]
  • 71.Trewhella J.et al., 2017 publication guidelines for structural modelling of small-angle scattering data from biomolecules in solution: An update. Acta Crystallogr. Sect. D Struct. Biol. 73, 710–728 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Saio T., Guan X., Rossi P., Economou A., Kalodimos C. G., Structural basis for protein antiaggregation activity of the trigger factor chaperone. Science 344, 1250494 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Wirth A. J., Gruebele M., Quinary protein structure and the consequences of crowding in living cells: Leaving the test-tube behind. BioEssays 35, 984–993 (2013). [DOI] [PubMed] [Google Scholar]
  • 74.Wu S.et al., Interaction between bacterial outer membrane proteins and periplasmic quality control factors: A kinetic partitioning mechanism. Biochem. J. 438, 505–511 (2011). [DOI] [PubMed] [Google Scholar]
  • 75.Alvira S., et al. , Trans-membrane association of the Sec and BAM complexes for bacterial outer-membrane biogenesis. bioRxiv:10.1101/589077 (2 July 2020).
  • 76.Gessmann D.et al., Outer membrane β-barrel protein folding is physically controlled by periplasmic lipid head groups and BamA. Proc. Natl. Acad. Sci. U.S.A. 111, 5878–5883 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Struyvé M., Moons M., Tommassen J., Carboxy-terminal phenylalanine is essential for the correct assembly of a bacterial outer membrane protein. J. Mol. Biol. 218, 141–148 (1991). [DOI] [PubMed] [Google Scholar]
  • 78.de Cock H., Struyvé M., Kleerebezem M., van der Krift T., Tommassen J., Role of the carboxy-terminal phenylalanine in the biogenesis of outer membrane protein PhoE of Escherichia coli K-12. J. Mol. Biol. 269, 473–478 (1997). [DOI] [PubMed] [Google Scholar]
  • 79.Maguire L., Stefferson M., Betterton M. D., Hough L. E., Design principles of selective transport through biopolymer barriers. Phys. Rev. E 100, 042414 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Wu R., Stephenson R., Gichaba A., Noinaj N., The big BAM theory: An open and closed case? Biochim. Biophys. Acta Biomembr. 1862, 183062 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Marx D. C., Fleming K. G., Influence of protein scaffold on side-chain transfer free energies. Biophys. J. 113, 597–604 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Lee J. J., Berns D. S., Protein aggregation. The effect of deuterium oxide on large protein aggregates of C-phycocyanin. Biochem. J. 110, 465–470 (1968). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Webb B., Sali A., Comparative protein structure modeling using MODELLER. Curr. Protoc. Bioinforma. 2016, 5.6.1-5.6.37 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.The PyMOL Molecular Graphics System (Version 1.3, Schrödinger, LLC, New York, NY).
  • 85.MacKerell A. D.et al., All-atom empirical potential for molecular modeling and dynamics studies of proteins. J. Phys. Chem. B 102, 3586–3616 (1998). [DOI] [PubMed] [Google Scholar]
  • 86.Phillips J. C.et al., Scalable molecular dynamics with NAMD. J. Comput. Chem. 26, 1781–1802 (2005). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Fiorin G., Klein M. L., Hénin J., Using collective variables to drive molecular dynamics simulations. Mol. Phys. 111, 3345–3362 (2013). [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary File
Supplementary File
pnas.2008175117.sd01.xlsx (128.3KB, xlsx)
Supplementary File
pnas.2008175117.sd02.xlsx (48.5KB, xlsx)
Supplementary File
pnas.2008175117.sd03.xlsx (48.6KB, xlsx)
Supplementary File
pnas.2008175117.sd04.xlsx (67.2KB, xlsx)
Supplementary File
pnas.2008175117.sd05.xlsx (66.4KB, xlsx)
Supplementary File

Data Availability Statement

All raw data and detailed protocols, including gel images, SANS profiles, and SurA–uOmpA171 models, are available at https://github.com/KarenGFleming/SurAuOmpA. SI Appendix includes detailed protocols and raw data associated with XL-MS experiments. All raw and analyzed mass spectra are available on ProteomeXchange under identifiers PXD021870 and PXD021872.


Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES